Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis

Yoshio Kobayashi; Roxana Mehran; Gary S Mintz; George Dangas; Issam Moussa; Michael Collins; Prabhtej Brara; Mehran Moussavian; Alexandra J Lansky; Gregg W Stone; Martin B Leon; Jeffrey W Moses; Paul S Teirstein

doi:10.1016/j.amjcard.2003.08.018

Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis

Am J Cardiol. 2003 Dec 1;92(11):1329-31. doi: 10.1016/j.amjcard.2003.08.018.

Authors

Yoshio Kobayashi¹, Roxana Mehran, Gary S Mintz, George Dangas, Issam Moussa, Michael Collins, Prabhtej Brara, Mehran Moussavian, Alexandra J Lansky, Gregg W Stone, Martin B Leon, Jeffrey W Moses, Paul S Teirstein

Affiliation

¹ Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA.

PMID: 14636914
DOI: 10.1016/j.amjcard.2003.08.018

Abstract

In-stent restenosis lesions were divided into 2 groups according to the use of cutting balloon (n = 76) or conventional balloon angioplasty (n = 407) before gamma-brachytherapy. Cutting balloon angioplasty, compared with conventional balloon angioplasty, in patients undergoing gamma-brachytherapy for in-stent restenosis is associated with less requirement for new stents (11% vs 22%, p = 0.02) but similar target vessel revascularization (35.1% vs 29.8%, p = 0.4) at follow-up.

Publication types

Clinical Trial
Clinical Trial, Phase III
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Angioplasty, Balloon / methods*
Brachytherapy*
Chi-Square Distribution
Combined Modality Therapy
Coronary Restenosis / therapy*
Female
Humans
Male
Middle Aged
Retrospective Studies
Stents*
Treatment Outcome